Here are two case studies that illustrate the complexity of GLP-1 usage in ED treatment: Case Study 1: Navigating Weight Loss Medications and ED Treatment Conflicts Client Profile: A 35-year-old female diagnosed with OSFED (Other Specified Feeding or Eating Disorder), PTSD, and Major Depressive Disorder entered Skyways Partial Hospitalization Program (PHP) to address trauma and ED symptoms
Food and Drug Administration and other cited public sources
The mechanistic consequence is that GHRP-6 activates the full biological program that ghrelin controls not just GH secretion, but somatostatin suppression, appetite signaling via NPY/AgRP pathways, gastric motility, and elements of the reward circuitry
Cellular energy.*
INGREDIENTS: Water, Preservative (potassium sorbate, E-202), Orange flavour, lemon essential oil, sweetener (Sucralose), Thickener (Xanthan-gum, E-415)